Evidence map›Paper›PMID 34375100›Full record

ArticleMolecular pharmaceutics2021

Drug-Polymer Interactions in Acetaminophen/Hydroxypropylmethylcellulose Acetyl Succinate Amorphous Solid Dispersions Revealed by Multidimensional Multinuclear Solid-State NMR Spectroscopy.

Andrea Pugliese, Michael Toresco, Daniel McNamara, Dinu Iuga, Anuji Abraham, Michael Tobyn, Lucy E Hawarden, Frédéric Blanc

Open access · hybridAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 38 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2026
    Article
  2. CharacterizingMolecular pharmaceutics · 2025
    Article
  3. Article
  4. Revealing the Local Structure and Dynamics of the Solid Li Ion Conductor LiChemistry of materials : a publication of the American Chemical Society · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Optimisation ofPhysical chemistry chemical physics : PCCP · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Andrea PuglieseDepartment of Chemistry, University of Liverpool, Crown Street, Liverpool L69 7ZD, United Kingdom.ORCID 0000-0001-7328-0670
Michael TorescoChemical Engineering Department, Rowan College of Engineering, Rowan University, Mullica Hill Road, Glassboro, New Jersey 08028, United States.
Daniel McNamaraDrug Product Development, Bristol-Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States.ORCID 0000-0001-5785-2405
Dinu IugaDepartment of Physics, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, United Kingdom.
Anuji AbrahamDrug Product Development, Bristol-Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States.
Michael TobynDrug Product Development, Bristol-Myers Squibb, Reeds Lane, Moreton CH46 1QW, United Kingdom.
Lucy E HawardenDrug Product Development, Bristol-Myers Squibb, Reeds Lane, Moreton CH46 1QW, United Kingdom.
Frédéric BlancDepartment of Chemistry, University of Liverpool, Crown Street, Liverpool L69 7ZD, United Kingdom.ORCID 0000-0001-9171-1454
Bristol-Myers Squibb (United Kingdom) · GBBristol-Myers Squibb (United States) · USUniversity of Liverpool · GBRowan University · USUniversity of Warwick · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

The bioavailability of insoluble crystalline active pharmaceutical ingredients (APIs) can be enhanced by formulation as amorphous solid dispersions (ASDs). One of the key factors of ASD stabilization is the formation of drug-polymer interactions at the molecular level. Here, we used a range of multidimensional and multinuclear nuclear magnetic resonance (NMR) experiments to identify these interactions in amorphous acetaminophen (paracetamol)/hydroxypropylmethylcellulose acetyl succinate (HPMC-AS) ASDs at various drug loadings. At low drug loading (<20 wt %), we showed that

Indexed as

AcetaminophenBiological AvailabilityChemistry, PharmaceuticalExcipientsHydrogen BondingHypromellose DerivativesMagnetic Resonance SpectroscopySolubilitySuccinic AcidAcetaminophenExcipientsHypromellose DerivativesSuccinic Acidacetaminophen (paracetamol)amorphous solid dispersiondrug−polymer interactionshydroxypropylmethylcellulose acetyl succinate (HPMC-AS)multidimensional NMRsolid-state NMR

Identifiers

PMID34375100
PMCPMC8424625
OpenAlexW3190589259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.